Dihexa (also called PNB-0408 or N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small synthetic peptide derived from angiotensin IV. In laboratory and animal studies, it stands out because it powerfully boosts the formation of new connections between brain cells — a process called synaptogenesis. Researchers found it can be up to 10 million times more potent than BDNF, one of the brain’s natural growth factors, when tested in certain cell-based assays.
It works by teaming up with a natural protein called Hepatocyte Growth Factor (HGF) and turning up the signaling at its receptor (c-Met). This leads to more dendritic spines and synapses in brain regions important for learning and memory, like the hippocampus. In rodent models designed to mimic Alzheimer’s-like problems or cognitive decline, Dihexa helped restore performance on memory tasks.
However, all of this impressive data comes from test tubes and animal studies. As of 2026, there are no published human clinical trials on Dihexa. It remains a research compound only. This ELEVATE Guide breaks down exactly what the science shows so far, in plain language, so you can understand the excitement around it while staying grounded in what’s actually been proven.
Introduction
Your brain is constantly rewiring itself. Every time you learn something new or form a memory, brain cells (neurons) grow tiny little branches called dendritic spines and form connections called synapses. These connections let signals jump from one cell to another. As we age, or after injury or disease, this ability can slow down or get damaged.
Scientists have long been interested in compounds that might help the brain grow more of these connections. One natural player is BDNF (brain-derived neurotrophic factor) — often called “fertilizer for the brain.” But BDNF doesn’t cross into the brain easily when taken as a supplement or drug, and its effects are limited in some situations.
Enter Dihexa. It was developed at Washington State University as a modified version of a piece of angiotensin IV (a small protein fragment). The goal was to create something that could get into the brain when taken orally and strongly encourage new synapse growth.
What makes Dihexa special in the research world is how dramatically it appears to work in lab dishes and in animals with cognitive challenges. Instead of just protecting existing brain cells, it seems to help build brand new connections. That’s why it gets attention in biohacking and longevity research circles — but remember, all the data right now is still at the research stage.
Literature Review
The story of Dihexa really starts with work on angiotensin IV and its effects on the brain. Researchers noticed that certain fragments could influence memory and learning in animals. They then created more stable, brain-penetrating versions — and Dihexa was one of the winners.
The key paper came out in 2014 from Benoist and colleagues. They showed that Dihexa doesn’t work alone. It binds very tightly to Hepatocyte Growth Factor (HGF), a natural repair and growth signal in the body. Once bound, Dihexa makes HGF much more effective at flipping the switch on its receptor, called c-Met.
Think of HGF like a key and c-Met like a lock on the surface of brain cells. Dihexa doesn’t just open the lock — it makes the key work way better, especially when there isn’t much HGF around. This super-charged signaling then triggers a cascade inside the cell that leads to the growth of new dendritic spines and synapses.
In lab dishes containing hippocampal neurons (the memory center of the brain), Dihexa caused a huge increase in these new connections. In one type of test measuring how well compounds promote neuron growth, Dihexa was seven orders of magnitude more potent than BDNF. That’s not a small difference — that’s millions of times stronger in that specific assay.
They also tested it in living animals. In rats that had memory problems induced by a drug (scopolamine) or in older rats with natural age-related decline, giving Dihexa orally helped them perform better on spatial memory tests (like finding a hidden platform in a water maze). Importantly, when they blocked the HGF/c-Met pathway with special inhibitors, the benefits disappeared. This proved that Dihexa’s effects really do depend on this specific growth pathway.
A later study in 2021 (Sun et al.) looked at Dihexa in another model of cognitive trouble and saw it could rescue performance while also affecting the PI3K/AKT signaling pathway — another important internal “growth and survival” highway inside cells.
One reassuring note from the research: even though c-Met is involved in some cancer processes, the studies so far have not seen Dihexa causing uncontrolled cell growth or tumors in the models tested. Scientists point out that turning on an oncogene (cancer-related gene) usually needs several other changes to actually cause cancer.
Overall, the published literature paints a picture of a compound with unusually strong synaptogenic (synapse-building) power in preclinical settings, working through a well-known repair pathway (HGF/c-Met).
Methodology/Data Analysis
Most of what we know comes from two main types of experiments: cell culture work and animal behavior studies.
In the lab dish (in vitro): Researchers grew hippocampal neurons in petri dishes and added Dihexa. They then used special dyes and microscopes to count dendritic spines and synapses. They compared it to BDNF and other compounds. They also used “antagonists” (blockers) and genetic tools (shRNA to silence c-Met) to prove the effect was happening through the HGF/c-Met route and not some other random pathway.
In living animals: They used rat models that mimic aspects of Alzheimer’s or age-related memory loss. One common test is the Morris water maze — rats have to learn where a hidden platform is in a pool of water. Better memory = faster learning and remembering the location. Dihexa was given orally, which is important because many brain compounds don’t survive digestion or cross the blood-brain barrier.
They measured not just behavior but also actual changes in brain tissue (more spines and synapses). The 2021 study added protein analysis to look at signaling pathways like PI3K/AKT being turned on.
What’s missing in the data: There are no large, well-controlled human studies. No published Phase 1 safety trials in healthy people, no dose-finding studies, and no long-term safety data. We don’t know how Dihexa behaves in the human body over weeks or months, how it interacts with other compounds, or whether the dramatic synapse growth seen in rats happens the same way in people.
The animal doses used in the studies are not directly translatable to humans without proper pharmacokinetic work, which hasn’t been published yet.
Discussion
Dihexa is genuinely exciting from a research perspective because it hits a core problem in brain aging and neurodegeneration: loss of connections between neurons. Many conditions (Alzheimer’s, traumatic brain injury, age-related cognitive decline) involve fewer synapses. A compound that potently encourages new ones to form is worth serious scientific attention.
The fact that it works through the HGF/c-Met system is smart — it’s piggy-backing on a natural repair mechanism rather than inventing something completely foreign. The oral activity and long apparent half-life (some reports suggest around a week) also make it interesting compared to peptides that have to be injected.
That said, we have to stay realistic. The jump from “works amazingly in rat brains and cell dishes” to “safe and effective for humans” is huge. Many compounds look spectacular in early research and then run into problems with side effects, dosing, or simply not working the same way in people.
Because c-Met is linked to cell growth, long-term safety (especially any theoretical cancer risk) needs careful study even though early data hasn’t raised red flags. We also don’t know if forcing lots of new synapses is always a good thing — the brain is very precise about its wiring.
For the biohacking and research community, Dihexa represents a fascinating example of how modifying a natural peptide fragment can create something with outsized effects on brain plasticity in the lab. It’s the kind of compound that sparks deeper questions: How exactly does enhanced synaptogenesis translate to better function? Can this pathway be safely targeted long-term? What happens when you combine it with other research tools that support brain health?
Right now, the honest answer is: we don’t know yet, because the human research simply hasn’t been done.
Conclusion
Dihexa is a research compound that, in laboratory and animal studies, shows remarkable ability to promote the growth of new brain connections through the HGF/c-Met pathway. It has demonstrated procognitive effects in models of impaired memory and stands out for its extreme potency compared to natural factors like BDNF in certain tests.
However, it remains exactly what it is labeled as: a research tool. There are currently no human clinical trials establishing safety, optimal use, or effectiveness in people. All discussion of its potential belongs strictly in the realm of scientific exploration and laboratory research.
As more data emerges from proper studies, we’ll get a clearer picture. Until then, compounds like Dihexa highlight how creative chemistry can unlock powerful biological pathways — and why rigorous, responsible research is essential before anything moves beyond the lab.
References
[1] Benoist CC et al. The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System. J Pharmacol Exp Ther. 2014.
[2] Sun X et al. AngIV-Analog Dihexa Rescues Cognitive Impairment and… (PI3K/AKT pathway study). 2021.
[3] Additional supporting literature from Washington State University research groups on angiotensin IV analogs and HGF/c-Met signaling.
FTC Disclosure: ELEVATE and ELEVATE Performance Marketing LLC maintain affiliate, referral, and marketing relationships with select research and wellness industry partners. We may receive compensation from purchases made through our links, discount codes, referrals, or other promotional partnerships.
Content shared by ELEVATE is intended solely for educational and informational purposes and should not be construed as medical advice. All statements, opinions, and recommendations expressed are our own.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Visit kimerachems.co and use code ELEVATE for 10% off your order of research compounds and peptides.
#Dihexa #PNB0408 #Synaptogenesis #HGF #cMet #BrainPlasticity #NeurotrophicResearch #CognitiveResearch #ResearchUseOnly #BiohackingScience #ELEVATEBiohacking #EvidenceBasedOptimization #LongevityResearch
Leave a Reply